May 10, 2016

Full Interview: GlaxoSmithKline CEO says "things have to change"

Share Now on:
HTML EMBED:
COPY
The CEO of pharmaceutical giant GlaxoSmithKline reflects on the industry

Sir Andrew Witty is the CEO of GlaxoSmithKline, a British pharmaceutical company that counts itself as one of the fifth or sixth largest in the industry. Marketplace host, Kai Ryssdal talked to him about the cost of pharmaceuticals, R&D and preparing for epidemics.

Click the audio player above or subscribe to the Corner Office podcast to listen to the full interview.